WAYS TO SUPPORT MY WORK Massive compound shakeup00:00:43 Why compound users need this00:01:25 Sponsor, Shed obesity care00:02:11 Breaking news changed everything00:02:28 OTP semaglutide exclusive00:03:28 DDC list explained00:04:24 Novos lab findings00:09:57 302% dose shocker00:13:03 Catalents contamination mess00:16:33 Lillys B12 tirzepatide bombshell00:19:34 Is the molecule changing?00:21:46 New oral GLP-1 contender Cheap Zepbound Incoming for Medicare, But CMS Just Issued a Catch On this episode of the podcast, host Dave Knapp breaks down the latest updates on potential GLP-1 receptor agonists coverage for people on Medicare living with obesity
Routine lab work, managing health markers and being mindful of mental side effects is all what I consider good style
You receive help through counseling, therapy, and educational sessions while still living at home
No, GLP-1s are generally not covered for weight loss under Medicare
Cartier Esham, Ph.D., and Elizabeth Jungman
So I think seeing the progression of that and looking at outcome studies will be key before we make a decision of whether or not we want to include that in our care. Road to Reimbursement Because GLP-1s are a new drug within health care in general and there are not yet any clinical standards for its use across substance use disorder care, serious mental illnesses or eating disorders, the road to eventual reimbursement for including it in care is one all practitioners told BHB they will be closely monitoring